バイオマテリアル（生体材料）の世界市場：金属系バイオマテリアル、セラミック系バイオマテリアル、ポリマー系バイオマテリアル、天然バイオマテリアル...市場調査レポートについてご紹介

1 Introduction (Page No. – 23)
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 27)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Research Design
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 38)
3.1 Introduction
3.2 Current Scenario
3.3 Future Scenario
3.4 Conclusion

4 Premium Insights (Page No. – 50)
4.1 Overview of the Global Market
4.2 Global Market, By Type
4.3 Geographic Analysis of the Market
4.4 Metallic Biomaterials Market, By Type
4.5 Geographic Snapshot of the Market

5 Market Overview (Page No. – 55)
5.1 Introduction
5.2 Biomaterials Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increased Funds and Grants By Government Bodies Worldwide
5.3.1.2 Growing Implantable Devices Market
5.3.1.3 High Growth Anticipated for Plastic Surgery and Wound Healing Applications
5.3.1.4 Research and Funding for Developing Novel Biomaterials to Boost Market for Cardiovascular Applications
5.3.1.5 Technological Advancements
5.3.1.6 Rising Number of Hip and Knee Replacement Procedures Worldwide
5.3.1.7 High Growth in the Geriatric Population Coupled With Growing Incidence of Cardiovascular Diseases
5.3.2 Restraints
5.3.2.1 Limitations of Biomaterial-Based Products
5.3.2.2 Stringent Clinical & Regulatory Processes
5.3.2.3 Unfavorable Healthcare Reforms in the U.S.
5.3.3 Opportunities
5.3.3.1 Growing Healthcare Market in Emerging Economies
5.3.3.2 Increasing Number of Free-Trade Agreements
5.3.4 Burning Issues
5.3.4.1 Biomaterials Access Assurance Act

6 Global Biomaterials Market, By Type of Material (Page No. – 67)
6.1 Introduction
6.2 Metallic Biomaterials
6.2.1 Stainless Steel
6.2.2 Titanium & Titanium Alloys
6.2.3 Cobalt-Chrome Alloys
6.2.4 Gold
6.2.5 Silver
6.3 Ceramics biomaterials
6.3.1 Calcium Phosphate
6.3.2 Zirconia
6.3.3 Aluminum Oxide
6.3.4 Calcium Sulfate
6.3.5 Carbon
6.3.6 Glass
6.4 Polymers biomaterials
6.4.1 Polymethylmethacrylate (PMMA)
6.4.2 Polyethylene
6.4.3 Polyester
6.4.4 Polyvinylchloride (PVC)
6.4.5 Silicone Rubber
6.4.6 Nylon
6.4.7 Polyetheretherketone (PEEK)
6.5 Natural Biomaterials
6.5.1 Hyaluronic Acid
6.5.2 Collagen & Gelatin
6.5.3 Fibrin
6.5.4 Cellulose
6.5.5 Chitin
6.5.6 Alginates
6.5.7 Silk

7 Biomaterials Market, By Application (Page No. – 101)
7.1 Introduction
7.2 Cardiovascular
7.2.1 Stents
7.2.2 Pacemakers
7.2.3 Implantable Cardiac Defiblillators
7.2.4 Heart Valves
7.2.5 Catheters
7.2.6 Vascular Grafts
7.2.7 Guidewires
7.2.8 Sensors
7.2.9 Others
7.3 Orthopedic
7.3.1 Joint Replacement
7.3.1.1 Knee Replacement (Arthroplasty)
7.3.1.2 Hip Replacement (Arthroplasty)
7.3.1.3 Shoulder Replacement (Arthroplasty)
7.3.1.4 Others
7.3.2 Viscosupplementation
7.3.2.1 Knee Osteoarthritis
7.3.2.2 Abdominal and Pelvic Surgeries
7.3.3 Bioresorbable Tissue Fixation Products
7.3.3.1 Suture Anchors
7.3.3.2 Interference Screws
7.3.3.3 Meniscal Repair Tacks
7.3.3.4 Meshes
7.3.4 Spine
7.3.4.1 Spinal Fusion
7.3.4.2 Minimally Invasive Fusion Surgeries
7.3.4.3 Motion Preservation& Dynamic Stabilization
7.3.4.3.1 Pedicle-Based Rod Systems
7.3.4.3.2 Interspinous Spacers
7.3.4.3.3 Disc Arthroplasty/Replacement
7.3.4.4 Demineralized Bone Matrix
7.3.5 Orthobiologics
7.3.5.1 Autografts
7.3.5.2 Allograft
7.3.5.3 Synthetics
7.3.5.4 Bone Morphogenetic Proteins (Bmps)
7.3.5.5 Growth Factors
7.3.5.6 Stem Cell Therapy
7.4 Ophthalmology
7.4.1 Contact Lenses
7.4.2 Intraocular Lenses
7.4.3 Functional Replacements of Ocular Tissues
7.4.4 Synthetic Corneas
7.4.5 Others
7.5 Dental
7.5.1 Dental Implants
7.5.2 Dental Bone Grafts & Substitutes
7.5.3 Dental Membranes
7.5.4 Tissue Regeneration
7.6 Plastic Surgery
7.6.1 Acellular Dermal Matrices
7.6.2 Soft Tissue Fillers
7.6.3 Facial Wrinkle Treatments
7.6.4 Bioengineered Skin
7.6.5 Craniofacial Surgery
7.6.6 Peripheral Nerve Repair
7.7 Wound Healing
7.7.1 Fracture Fixation Devices
7.7.1.1 Sutures
7.7.1.2 Staples
7.7.1.3 Bone Plates
7.7.1.4 Screws
7.7.1.5 Pins
7.7.1.6 Rods
7.7.1.7 Wires
7.7.2 Skin Substitutes
7.7.3 Surgical Hemostats
7.7.4 Internal Tissue Sealants
7.7.5 Adhesion Barriers
7.8 Tissue Engineering
7.8.1 Scaffolds for Regenerative Medicine
7.8.2 Nanomaterials for Biosensing
7.8.3 Self-Assembled Biomimetic Copolymers
7.8.4 Cell-Material Interface Engineering
7.8.5 Tailoring of Inorganic Nanoparticles
7.9 Neurological/Central Nervous System
7.9.1 Shunting Systems
7.9.2 Cortical Neural Prosthetics
7.9.3 Hydrogel Scaffolds for Cns Repair
7.9.4 Neural Stem Cell Encapsulation
7.1 Other Applications
7.10.1 Drug Delivery Systems
7.10.2 Gastrointestinal Applications
7.10.3 Bariatric Surgery
7.10.4 Urinary Applications

8 Global Biomaterials Market, By Region (Page No. – 201)
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Biomaterials-Based Research to Drive the U.S. Biomaterials Market
8.2.1.2 Growing Demand for Plastic Surgeries in the U.S.
8.2.1.3 Conferences on Biomaterials in the U.S.
8.2.1.4 Increase in Cancer Incidences
8.2.1.5 Growing Number of Cardiovascular Diseases to Bolster Growth
8.2.2 Canada
8.2.2.1 Increasing R&D Activities for Biomaterials in Canada
8.3 Europe
8.3.1 Germany
8.3.1.1 Rising Cases of Hip and Knee Replacements
8.3.1.2 Growing Medical Devices Industry in Germany
8.3.2 U.K.
8.3.2.1 Increased Funds, and Grants By Government Bodies & Universities
8.3.2.2 Rise in Cvd Prevalence in the U.K.
8.3.2.3 Conferences & Annual Meetings
8.3.2.4 Rising Cosmetic Surgery in the U.K. to Trigger Market Growth
8.3.3 France
8.3.3.1 Favorable Government Support and Growing Aging Population
8.3.4 Rest of Europe (RoE)
8.3.4.1 Improving Healthcare Structure in Russia
8.3.4.2 Increasing Research Activities on Biomaterials in Spain
8.3.4.3 Spain & Poland: Rising Incidence of Cardiovascular Disease, Growth in the Medical Tourism Industry, and Aging Population
8.4 Asia-Pacific
8.4.1 International Alliances to Boost the Biomaterials Market
8.4.2 Japan
8.4.2.1 Japan’s Growing Healthcare Industry
8.4.3 China
8.4.3.1 Lucrative Medical Devices Industry in China
8.4.3.2 New, Favorable Tax Policy
8.4.3.3 Growing Aging Population
8.4.4 India
8.4.4.1 India, A Hotspot for Cosmetic and Plastic Surgery
8.4.4.2 Increasing Geriatric Population in India
8.4.5 Rest of Asia-Pacific (RoAPAC)
8.4.5.1 Rising Cases of Hip and Knee Replacement Procedures in Australia
8.4.5.2 Regulations Limiting the Growth of the Biomaterials Market in Indonesia
8.4.5.3 Increasing Research Activities in Australia, Singapore, and Hong Kong
8.5 Rest of the World (Row)
8.5.1 Increasing Aging Population and the Subsequent Rise in Age-Related Disorders in the Middle East
8.5.2 Rising Obesity in Latin America
8.5.3 Opportunities in the Healthcare System in Brazil
8.5.4 Increasing Aging Population Coupled With Increasing Cases of Cardiovascular Diseases in Brazil
8.5.5 Market Scenario in Latin America and South Africa

9 Competitive Landscape (Page No. – 241)
9.1 Competitive Situation and Trends
9.1.1 Acquisitions
9.1.2 Agreements, Alliances, Partnerships, Joint Ventures, and Collaborations
9.1.3 New Product Launches
9.1.4 Expansions
9.1.5 Other Developments

10 Company Profiles (Page No. – 249)
10.1 Royal DSM
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Services Offered
10.1.4 Recent Developments
10.2 BASF SE
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Recent Developments
10.3 Bayer AG
10.3.1 Business Overview
10.3.2 Products Offered:
10.3.3 Recent Developments
10.4 Invibio Ltd. (Subsidiary of Victrex PLC)
10.4.1 Business Overview
10.4.2 Products Offered:
10.4.3 Recent Developments
10.5 Wright Medical Technology, Inc.
10.5.1 Business Overview
10.5.2 Products Offered:
10.5.3 Recent Developments
10.6 Carpenter Technology Corporation
10.6.1 Business Overview
10.6.2 Product Offerings
10.6.3 Recent Developments
10.7 Corbion N.V.
10.7.1 Products Offered:
10.7.2 Services Offered
10.7.3 Recent Developments
10.8 Covalon Technologies Ltd.
10.8.1 Business Overview
10.8.2 Products Offered:
10.8.3 Recent Developments
10.9 Evonik Industries AG
10.9.1 Products Offered:
10.9.2 Services Offered
10.9.3 Recent Developments
10.10 Zimmer Biomet Holdings, Inc. (A Subsidiary of Zimmer Holdings, Inc.)
10.10.1 Business Overview
10.10.2 Products Offered:
10.10.3 Recent Developments
10.11 Berkeley Advanced Biomaterails, Inc.
10.11.1 Products Offered:
10.12 Cam Bioceramics Bv
10.12.1 Business Overview
10.12.2 Products Offered
10.12.3 Services Offered
10.13 Collagen Matrix, Inc.
10.13.1 Products Offered:

11 Appendix (Page No. – 280)
11.1 Discussion Guide
11.2 Company Developments (2012–2015)
11.2.1 Royal DSM
11.2.2 Wright Medical Technology, Inc.
11.2.3 Evonik Industries AG
11.3 Introducing RT: Real-Time Market Intelligence
11.4 Available Customizations
11.5 Related Report